- A Case of Prolonged Hypogammaglobulinemia after Rituximab-Containing Chemotherapy in a Patient with Lymphoma
-
Noh HJ, Gong BH, Kim YS, Jung YH, Woo IS, Han CW
- KMID: 2269250
- Korean J Med.
- 2014 Sep;87(3):357-362.
- doi: 10.3904/kjm.2014.87.3.357
Rituximab, an anti-CD20 monoclonal antibody, is an effective target agent against the B lymphocytes in B-cell lymphoid malignancies and various lymphoproliferative diseases. Moreover, the toxicity of rituximab is less severe... -
- CITED
-
- Close
- SHARE
-
- Close
